Inventor · disambiguated record
Wim Van De Vreken
Also filed as: VAN DE VREKEN WIM
9 granted patents·2 pending applications·61 citations·filing 2003–2013
83Inventor score
Technology areasA61P
Files withTIBOTEC PHARM LTD3SIMMEN KENNETH ALAN2TIBOTEC BVBA2JANSSEN SCIENCES IRELAND UC1KESTELEYN BART RUDOLF ROMANIE1
Top patents by PatentIndex Score
11 records- 0193US7622582B2Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-oneTIBOTEC BVBA·Filed 2005·Granted Nov 24, 2009·42 cites·10 claims
- 0285US7989471B2Macrocyclic inhibitors of hepatitis C virusTIBOTEC PHARM LTD·Filed 2006·Granted Aug 2, 2011·10 cites·16 claims
- 0379US8012939B2Macrocyclic inhibitors of hepatitis C virusTIBOTEC PHARMACEUTICALS LTD CO·Filed 2006·Granted Sep 6, 2011·8 cites·11 claims
- 0457US8637663B2Macrocyclic inhibitors of hepatitis C virusRABOISSON PIERRE JEAN-MARIE BERNARD·Filed 2007·Granted Jan 28, 2014·0 cites·13 claims
- 0555US7608726B2Substituted indolepyridinium as anti-infective compoundsTIBOTEC PHARM LTD·Filed 2003·Granted Oct 27, 2009·1 cites·17 claims
- 0654US9365582B2Macrocyclic inhibitors of hepatitis C virusJANSSEN SCIENCES IRELAND UC·Filed 2013·Granted Jun 14, 2016·0 cites·9 claims
- 0753US8183277B2Macrocylic inhibitors of hepatitis C virusSIMMEN KENNETH ALAN·Filed 2006·Granted May 22, 2012·0 cites·12 claims
- 0851US2010048563A1Substituted indolepyridinium as anti-infective compoundsKESTELEYN BART RUDOLF ROMANIE·Filed 2009·Application pending·0 cites
- 0949US8754116B2Macrocyclic inhibitors of hepatitis C virusSIMMEN KENNETH ALAN·Filed 2012·Granted Jun 17, 2014·0 cites·12 claims
- 1040US7514427B21,5,6,-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-inflective agentsTIBOTEC PHARM LTD·Filed 2006·Granted Apr 7, 2009·0 cites·11 claims
- 1139US2007238727A15-Substituted 1-Phenyl-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones and Analogs as Anti-ViralsTIBOTEC BVBA·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wim Van De Vreken files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →